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AbstrAct
Background Out-of-hospital cardiac arrest (OHCA) is 
often the first manifestation of unrecognised cardiac 
disease. ECG abnormalities encountered in primary care 
settings may be warning signs of OHCA.
Objective We examined the association between common 
ECG abnormalities and OHCA in a primary care setting.
Methods We cross-linked individuals who had an ECG 
recording between 2001 and 2011 in a primary care 
setting with the Danish Cardiac Arrest Registry and 
identified OHCAs of presumed cardiac cause.
Results A total of 326 227 individuals were included 
and 2667 (0,8%) suffered an OHCA. In Cox regression 
analyses, adjusted for age and sex, the following ECG 
findings were strongly associated with OHCA: ST-
depression without concomitant atrial fibrillation (HR 
2.79; 95% CI 2.45 to 3.18), left bundle branch block 
(LBBB; HR 3.44; 95% CI 2.85 to 4.14) and non-specific 
intraventricular block (NSIB; HR 3.15; 95% CI 2.58 to 
3.83). Also associated with OHCA were atrial fibrillation 
(HR 1.89; 95% CI 1.63 to 2.18), Q-wave (HR 1.75; 95% 
CI 1.57 to 1.95), Cornell and Sokolow-Lyon criteria for 
left ventricular hypertrophy (HR 1.56; 95% CI 1.33 to 
1.82 and HR 1.27; 95% CI 1.12 to 1.45, respectively), 
ST-elevation (HR 1.40; 95% CI 1.09 to 1.54) and right 
bundle branch block (HR 1.29; 95% CI 1.09 to 1.54). The 
association between ST-depression and OHCA diminished 
with concomitant atrial fibrillation (HR 1.79; 95% CI 1.42 
to 2.24, p < 0.01 for interaction). Among patients suffering 
from OHCA, without a known cardiac disease at the time 
of the cardiac arrest, 14.2 % had LBBB, NSIB or ST-
depression.
Conclusions Several common ECG findings obtained 
from a primary care setting are associated with OHCA.
IntROduCtIOn
Cardiac arrest and sudden cardiac death are 
commonly observed among persons with 
established cardiovascular disease.1 It has 
been reported, however, that 40%–60% of all 
sudden cardiac deaths occur as the first mani-
festation of previously unrecognised heart 
disease. This challenges potential preventive 
steps for patients at high risk of suffering an 
out-of-hospital cardiac arrest (OHCA).2 3 The 
ECG is an inexpensive and widely available 
examination for detecting cardiac diseases, 
and several studies have shown that ECG 
findings such as left ventricular hypertrophy 
Key questions
What is already known about this subject?
 ► About 50% of out-of-hospital cardiac arrests 
(OHCAs) occur as the first manifestation of previ-
ously unrecognised heart disease. This challenges 
preventive steps for identifying patients at risk. 
Various ECG abnormalities have been associated 
with an increased risk of sudden cardiac death 
but routine ECG screenings of populations are not 
recommended. In primary care settings, ECG exam-
inations are very common. Consequently, when an 
ECG abnormality is encountered, knowledge about 
the associated risk of OHCA is important as patients 
could be referred for secondary care evaluation and 
ultimately treatment for an underlying heart disease.
What does this study add?
 ► Using a large contemporary primary care population 
referred for ECG recording, we examined the risk of 
OHCA of presumed cardiac cause based on com-
monly encountered ECG abnormalities. We found 
that several of such commonly encountered ECG 
abnormalities conferred a significantly increased 
absolute risk of OHCA. Especially left bundle branch 
block (LBBB), non-specific intraventricular block 
(NSIB) and ST-depression without concomitant atrial 
fibrillation were important risk markers.
How might this impact on clinical practice?
 ► When ECG findings are encountered in primary care 
settings such as LBBB, ST-depression without con-
comitant atrial fibrillation and NSIB, preventive mea-
sures such as referring the patient to a secondary 
care evaluation should be considered.
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(LVH), left bundle branch block (LBBB), pathological 
Q-waves and ST-segment deviations are associated with 
increased cardiac morbidity and mortality.4–10 Routine 
ECG screening of asymptomatic persons is not recom-
mended.3 11 Nevertheless, in a primary care setting, ECG 
examinations are commonly performed on a routine 
basis on a large variety of patients. Consequently, knowl-
edge about risks of cardiac arrest related to commonly 
encountered ECG findings is important as this could 
prove a tool for identifying otherwise unidentified high-
risk patients.
Using a large contemporary primary care population 
referred for ECG recording, we examined the risk of 
OHCA of presumed cardiac cause based on commonly 
encountered ECG abnormalities.
MetHOds
We studied individuals from the Copenhagen ECG 
study, comprising a large cohort of primary care patients 
referred to a central core facility (Copenhagen General 
Practitioners’ Laboratory (CGPL)) for digital ECG 
recordings, from 1 June 2001 to 26 September 2011. 
Further details on the population have been described 
previously.12
Out-of-hospital cardiac arrests
OHCAs were identified using the Danish Cardiac Arrest 
Registry from 1 June 2001 until 31 December 2012.13 
The Cardiac Arrest Registry is a nation-wide registry and 
includes clinical conditions of cardiac arrest outside of 
hospital that resulted in a resuscitative effort either by 
bystanders (an individual who witnessed the collapse or 
found the person unresponsive) or by emergency medical 
service personnel. Only first-time OHCAs of presumed 
cardiac cause were considered in this study. Presumed 
cardiac cause of the arrest was defined using death certif-
icates and/or discharge diagnoses consistent with cardiac 
disease, unknown disease or unexpected collapse. Death 
certificates and discharge diagnoses with other causes 
defined a non-cardiac cause of arrest, including trauma, 
drug overdose, suicide, and violent attack.13 Patients 
suffering a cardiac arrest of presumed non-cardiac cause 
were included in the cohort and followed as the rest of 
the population.
eCG analysis and interpretation
All ECGs were digitally recorded and stored in the 
MUSE Cardiology Information System (GE Healthcare, 
Wauwatosa, WI, USA). The ECGs were processed by the 
Marquette 12SL algorithm, V.21.
We used the 12SL algorithm to identify atrial fibril-
lation, atrial flutter, LBBB, right bundle branch block 
(RBBB) and 12SL measurements to code the following 
composite ECG criteria: Q-waves, ST-deviations, Sokolow-
Lyon and Cornell voltage criteria for LVH and non-spe-
cific intraventricular block (NSIB).14 ECGs with NSIB 
were identified as ECGs with QRS duration >120 ms 
without fulfilling criteria for RBBB or LBBB. Significant 
ST-T deviations and pathologic Q-waves (as a sign of 
prior myocardial infarction) were defined according to 
the Third Universal Myocardial Infarction Definition.15 
The definition of ST-elevation was slightly modified as 
the measurement of the ST segment was performed at 
QRS offset plus 1/16 of the average RR interval known 
as the STM point measure in the 12SL algorithm (equiv-
alent to about 80 ms after QRS offset in most cases). This 
measurement point was selected instead of the J-point 
because a notched or slurred appearance of the terminal 
QRS complex (also described as early repolarisation) 
can make it difficult to define the J-point.12 LBBB and 
NSIB are known to affect the repolarisation of the heart 
causing ST-deviations.15–17 Consequently, when ST-T devi-
ation was concomitantly present with LBBB or NSIB, we 
disregarded the finding. In patients with RBBB, ST-T devi-
ations in V1–V3 are common.15 When ST-T deviations in 
V1–V3 were present together with RBBB, the ST-T devia-
tions were disregarded.
The Sokolow-Lyon and Cornell sex-specific voltage 
criteria were used to identify ECG LVH.18 19 The criteria 
for hypertrophy have low predictive value when applied 
on an ECG with identified LBBB, RBBB and NSIB.20 
ST-T deviations together with ECGs with hypertrophy 
have been associated with larger left ventricular mass and 
risk of cardiovascular disease.20 Consequently, if LBBB, 
RBBB or NSIB were identified, ECGs were not assigned 
the Sokolow-Lyon and Cornell hypertrophy criteria. ST-T 
deviations together with the hypertrophy criteria were 
acknowledged and included in the analysis. In accor-
dance with the Third Universal Myocardial Infarction 
Definition, Q-waves, as a sign of prior myocardial infarc-
tion, were only defined when hypertrophy criteria or 
LBBB were absent.15
Patient characteristics, comorbidities and medication
In Denmark, all citizens have a unique civil registra-
tion number enabling linkage of information between 
various national registries on an individual level. Using 
the civil registration number for our study participants, 
we obtained data regarding age, sex and vital status 
from The Danish National Population Registry. We used 
discharge and outpatient diagnoses from the Danish 
National Patient Registry to classify patient comorbidity 
prior to the start of follow-up on an individual level. 
Causes of death were collected from the Danish Registry 
of Causes of Death. All discharge diagnoses and causes 
of death were classified according to the WHO Interna-
tional Classification of Diseases, 10th Edition. Medicine 
use was collected from the Danish National Prescription 
Registry, which contains all dispensed prescriptions from 
Danish pharmacies since 1995 and is classified according 
to the Anatomical Therapeutic Chemical System.
We identified patient comorbidity up until 5 years 
before the baseline ECG recording and redemption of 
prescriptions up until 180 days before the ECG recording. 
Cardiac diseases were defined from cardiac disease 
diagnosis, including ischaemic heart disease, previous 
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Table 1 Characteristics of the study population
Variable Censored
Death from other 
cause
Out-of-hospital 
cardiac arrest Total
Count, no. 270 825 52 735 2667 326 227
Median age in years (Q1–Q3) 53.1 [40.2, 64.6) 78.8 [69.2, 85.4) 72.5 [62.3, 80.7) 57.1 [43.0, 70.2)
Male sex, no. (%) 122 412 (45.2) 23 229 (44.0) 1650 (61.9) 147 291 (45.1)
Atrial fibrillation 5073 (1.9) 6487 (12.3) 337 (12.6) 11 897 (3.6)
Atrial flutter 502 (0.2) 478 (0.9) 23 (0.9) 1003 (0.3)
Cornell LVH 7570 (2.8) 4916 (9.3) 235 (8.8) 12 721 (3.9)
Sokolow-Lyon LVH 16 801 (6.2) 5486 (10.4) 339 (12.7) 22 626 (6.9)
Left bundle branch block 2037 (0.8) 1741 (3.3) 124 (4.6) 3902 (1.2)
Non-specific intraventricular block 2526 (0.9) 889 (1.7) 109 (4.1) 3524 (1.1)
Right bundle branch block 4346 (1.6) 3213 (6.1) 145 (5.4) 7704 (2.4)
Q-wave 14 093 (5.2) 7106 (13.5) 431 (16.2) 21 630 (6.6)
ST-depression without AF 4585 (1.7) 4635 (8.8) 309 (11.6) 9529 (2.9)
ST-depression with AF 961 (0.4) 2228 (4.2) 117 (4.4) 3306 (1.0)
ST-elevation 2867 (1.1) 889 (1.7) 66 (2.5) 3822 (1.2)
Cardiac disease
  Cardiomyopathy 656 (0.2) 491 (0.9) 46 (1.7) 1193 (0.4)
  Heart failure 2746 (1.0) 4830 (9.2) 339 (12.7) 7915 (2.4)
  Ischaemic heart disease (MI not included) 9884 (3.6) 6167 (11.7) 408 (15.3) 16 459 (5.0)
  Previous MI 3285 (1.2) 2134 (4.0) 168 (6.3) 5587 (1.7)
  AF/atrial flutter 5339 (2.0) 5872 (11.1) 305 (11.4) 11 516 (3.5)
  Valvular heart disease 1034 (0.4) 1189 (2.3) 84 (3.1) 2307 (0.7)
  Congenital heart disease 220 (0.1) 29 (0.1) 4 (0.1) 253 (0.1)
  Other cardiac arrythmia 3465 (1.3) 1676 (3.2) 83 (3.1) 5224 (1.6)
  Other cardiac disease 1148 (0.4) 538 (1.0) 33 (1.2) 1719 (0.5)
Other diseases
  Cerebrovascular disease 5967 (2.2) 6005 (11.4) 251 (9.4) 12 223 (3.7)
  Peripheral vascular disease 2615 (1.0) 2868 (5.4) 154 (5.8) 5637 (1.7)
  COPD 5680 (2.1) 5405 (10.2) 271 (10.2) 11 356 (3.5)
  Malignant disease 8101 (3.0) 6206 (11.8) 183 (6.9) 14 490 (4.4)
  Renal disease 862 (0.3) 937 (1.8) 45 (1.7) 1844 (0.6)
  Liver disease 2223 (0.8) 1000 (1.9) 48 (1.8) 3271 (1.0)
Medication
  QTc prolonging medication 62 801 (23.2) 19 338 (36.7) 807 (30.3) 82 946 (25.4)
  Glucose lowering medication 15 344 (5.7) 5684 (10.8) 369 (13.8) 21 397 (6.6)
  Beta-blockers 26 436 (9.8) 10 183 (19.3) 629 (23.6) 37 248 (11.4)
  Diuretics 41 951 (15.5) 25 643 (48.6) 1300 (48.7) 68 894 (21.1)
  ACEi/ARB 48 444 (17.9) 14 989 (28.4) 960 (36.0) 64 393 (19.7)
  Calcium inhibitors 27 745 (10.2) 10 821 (20.5) 639 (24.0) 39 205 (12.0)
All results are reported as the number of patients (%) unless otherwise specified.
ACEi/ARB, ACE inhibitor/angiotensin II receptor blockers; AF, atrial fibrillation; COPD, chronic obstructive pulmonary disease; LVH, left 
ventricular hypertrophy; MI, myocardial infarction; Q1–Q3, 1st+3rd quartiles.
myocardial infarction, cardiomyopathy, heart failure, 
valvular heart disease, atrial fibrillation, atrial flutter, 
congenital heart disease, other cardiac arrhythmias and 
other cardiac diseases (online supplementary material, 
table S1). As non-cardiac comorbidities, we included 
cerebrovascular disease, peripheral vascular disease, 
malignant disease, renal disease, liver disease and chronic 
obstructive pulmonary disease (online supplementary 
material, table S1). The data quality in the Danish regis-
tries of the diagnoses in this study has previously been 
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shown to be high.21 Medication included the following: 
QTc prolonging medication, glucose lowering medicine, 
beta-blockers, diuretics, ACE inhibitors/angiotensin 
receptor blockers and calcium channel blockers (online 
supplementary material, table S2-S3).
study population
We excluded ECGs identified by the 12SL algorithm 
as poor quality ECGs. ECGs with pacemaker rhythms, 
as identified by the 12SL algorithm or by an ECG tech-
nician or consultant in cardiology at CGPL, were also 
excluded.12 In addition, we excluded ECGs with second 
or third degree atrioventricular block, ECGs not quali-
fied for sufficient interpretation, ECGs where the patient 
had a pacemaker or implantable cardioverter-defibril-
lator implant prior to the ECG acquisition date, patients 
younger than 16 years, ECGs from patients with missing 
information regarding sex or cause of arrest and ECGs 
other than the latest acquired ECG before OHCA or 
censoring were also excluded. Information on the accu-
racy of the 12SL algorithm can be found in the online 
supplementary material.
statistics
Dichotomous variables were reported as frequencies 
with corresponding percentages and continuous varia-
bles were reported as medians and first to third quartiles 
(Q1–Q3). Individuals were followed from the day of the 
first ECG recording at CGPL (baseline ECG) and until 
an event of OHCA, death from other cause, emigration 
or 31 December 2012, whichever came first. Cause-spe-
cific Cox regression, with time since ECG recording as 
time scale, was used to estimate the association of the 
different baseline ECG findings and OHCA. Results are 
presented as cause-specific HRs with corresponding 
95% CI. The assumption of proportional hazards was 
evaluated using Schoenfeld residuals and were not 
violated.
First, a multivariable cause-specific Cox regression 
analysis was constructed with all ECG criteria in the same 
model, adjusted for age and sex. We tested for interac-
tions between the various ECG criteria. Only interaction 
terms with p<0.01 were considered for inclusion in the 
multivariable model. Second, we performed a multivari-
able analysis with additional inclusion of comorbidities 
and medication use, as listed in table 1 and supplemen-
tary material, tables S1-S3, except for congenital heart 
disease due to few events. Third, we estimated person-spe-
cific absolute 10-year risks of OHCA for women and men 
at age 50, 60 or 70 years old, with or without known 
cardiac disease by combining cause-specific Cox regres-
sion models for OHCA and death from other causes.22 
For these analyses, 95% bootstrap confidence intervals 
were estimated.
Data management and analysis were performed using 
SAS 9.4 (SAS Institute, Gary, NC, USA) and R (R Devel-
opment Core Team).
Results
A total of 326 227 patients had an ECG recording during 
the study period and fulfilled the inclusion criteria 
(figure 1).
The total follow-up time of the study population was 
1 506 274 person-years with a median follow-up time of 
4.0 years (Q1–Q3: 2.2–6.6 years). During the follow-up 
period, 2667 patients suffered an OHCA, 52 735 died 
from other cause and 6136 emigrated before the end of 
the study period. The incidence of OHCA was 177 (95% 
CI 153 to 205) per 100 000 person-years.
Table 1 shows the clinical characteristics of the study 
population for patients suffering from OHCA, compared 
with patients who were censored or died. The median age 
of patients suffering from OHCA was 72.5 years (Q1–Q3: 
62.3–80.7), compared with 78.8 (Q1–Q3: 69.2–85.4) years 
of patients who died from other cause and 53.1 years (Q1–
Q3: 40.2–64.6) of censored patients. Patients suffering from 
OHCA were more frequently male than patients who were 
censored or died (61.9% vs 45.2% and 44.0%, respectively). 
Compared with patients who died, patients suffering from 
OHCA had more ECG abnormalities, except atrial fibril-
lation, atrial flutter, Cornell LVH, and RBBB. In general, 
patients suffering from OHCA had more cardiac comor-
bidities, except congenital heart disease, and more patients 
suffering from OHCA received pharmacological treatment 
than patients who died or were censored.
For the patients suffering from OHCA, 30.0% (801 of 
2667) had a known cardiac disease at the time of the ECG 
recording, whereas 49.3% (1315 of 2667) of the patients 
had a known cardiac disease when the OHCA occurred. 
Notably, 14.2% of the patients without identified cardiac 
disease at the time of the OHCA had LBBB, NSIB or 
ST-depression without concomitant atrial fibrillation at 
the time of the ECG recording (table 2).
Association between eCG abnormalities and OHCA
Figure 2 shows the results of the multivariable Cox model, 
adjusted for age and sex. Overall, the different ECG 
abnormalities were all associated with OHCA, except 
atrial flutter. The following ECG findings were strongly 
associated with OHCA: LBBB (HR 3.44; 95% CI 2.85 to 
4.14) and NSIB (HR 3.15; 95% CI 2.58 to 3.83). Likewise, 
ST-depression without atrial fibrillation was highly associ-
ated with OHCA (HR 2.79; 95% CI 2.45 to 3.18), but the 
association between ST-depression and OHCA decreased 
when atrial fibrillation was concomitantly present in the 
ECG (HR 1.79; 95% CI 1.42 to 2.24, p<0.01 for interac-
tion between ST-depression and atrial fibrillation). Male 
sex compared with female sex was associated with OHCA 
(HR 2.21; 95% CI 2.04 to 2.41).
Online supplementary material, figure 1 shows the 
results of the multivariable fully adjusted Cox model. 
Overall, the associations between the different ECG 
abnormalities and OHCA remained.
ten-year risk of OHCA
Figure 3A, B shows the 10-year risks of OHCA for men and 
women with and without the different ECG abnormalities, 
 o
n
 19 July 2019 by guest. Protected by copyright.
http://openheart.bmj.com/
O
pen Heart: first published as 10.1136/openhrt-2018-000905 on 21 M
ay 2019. Downloaded from
 
5Søndergaard MM, et al. Open Heart 2019;6:e000905. doi:10.1136/openhrt-2018-000905
Cardiac risk factors and prevention
Figure 1 The selection process of the ECG study population. ICD, implantable cardioverter-defibrillator; OHCA, out-of-
hospital cardiac arrest.
known cardiac disease at ages 50, 60 and 70 years. For 
women, the 10-year risks of OHCA were overall half of 
the risks for males with the same ECG abnormalities 
(figure 3B). For both women and men, especially LBBB, 
ST-depression or NSIB posed a higher risk of OHCA 
compared with not having the ECG abnormalities. This 
was consistent for both patients with and without known 
cardiac disease. Online supplementary figure 2ab shows 
5-year risk.
dIsCussIOn
This study shows that several frequently encountered 
ECG abnormalities in a primary care setting were associ-
ated with increased risk of OHCA. Especially LBBB, NSIB 
and ST-depression without concomitant atrial fibrillation 
were strongly associated with OHCA. The 10-year abso-
lute risk of OHCA was highest for patients having LBBB, 
NSIB and ST-depression with known cardiac disease. 
Furthermore, patients without cardiac disease but with 
LBBB, NSIB and ST-depression also had high absolute 
risks compared with patients not having these ECG 
abnormalities.
Previous studies have assessed the association between 
different ECG abnormalities and sudden death. Intra-
ventricular block, including LBBB, has been described 
as a risk factor for sudden cardiac death and increased 
mortality.6 23 24 In our study, LBBB and NSIB were both 
highly associated with OHCA. Furthermore, some of the 
patients without known cardiac disease at the time of the 
OHCA event actually had these ECG abnormalities when 
the ECG was recorded. ST-depression has been associ-
ated with cardiovascular death and is a known indicator 
of myocardial ischaemia.12 15 In our study, ST-depression 
was strongly associated with OHCA but diminished when 
concomitantly present with atrial fibrillation. ST-depres-
sion during atrial fibrillation has been described as a 
poor predictor of coronary artery disease.25 Nonetheless, 
a recent study described an association between atrial 
fibrillation and non-ST-elevation myocardial infarction.26 
Pathological Q-waves and Cornell or Sokolow-Lyon 
voltage criteria for LVH were not as strongly associated 
with OHCA as ST-depressions, LBBB and NSIB. Both are 
known to have poor sensitivity.27 28 This could explain our 
findings as both pathological Q-waves and LVH are known 
 o
n
 19 July 2019 by guest. Protected by copyright.
http://openheart.bmj.com/
O
pen Heart: first published as 10.1136/openhrt-2018-000905 on 21 M
ay 2019. Downloaded from
 
Open Heart
6 Søndergaard MM, et al. Open Heart 2019;6:e000905. doi:10.1136/openhrt-2018-000905
Table 2 ECG abnormalities and patient characteristics for patients suffering from out-of-hospital cardiac arrest according to 
whether the patients had cardiac disease when the cardiac arrest occurred
Variable
Out-of-hospital 
cardiac patients with 
cardiac disease*
Out-of-hospital 
cardiac patients 
without cardiac 
disease* Total
Count, no. 1315 1352 2667
Median age in years (Q1–Q3) 75.3 [65.5, 82.3) 69.5 [59.6, 78.4) 72.5 [62.3, 80.7)
Male sex, no. 834 (63.4) 816 (60.4) 1650 (61.9)
Median follow-up (Q1–Q3) 1.9 [0.7, 4.0) 1.7 [0.6, 3.7) 1.8 [0.6, 3.8)
Atrial fibrillation 287 (21.8) 50 (3.7) 337 (12.6)
Atrial flutter 20 (1.5) 3 (0.2) 23 (0.9)
Cornell LVH 145 (11.0) 90 (6.7) 235 (8.8)
Sokolow-Lyon LVH 185 (14.1) 154 (11.4) 339 (12.7)
Left bundle branch block 77 (5.9) 47 (3.5) 124 (4.6)
Non-specific intraventricular block 71 (5.4) 38 (2.8) 109 (4.1)
Right bundle branch block 89 (6.8) 56 (4.1) 145 (5.4)
Q-wave 259 (19.7) 172 (12.7) 431 (16.2)
ST-depression without atrial fibrillation 202 (15.4) 107 (7.9) 309 (11.6)
ST-depression with atrial fibrillation 99 (7.5) 18 (1.3) 117 (4.4)
ST-elevation 46 (3.5) 20 (1.5) 66 (2.5)
All results are reported as the number of patients (%) unless otherwise specified.
Q1–Q3 1st+3rd quartiles.
*Cardiac disease at the time of the cardiac arrest: heart failure, ischaemic heart disease, prior myocardial infarction, cardiomyopathy, atrial 
fibrillation, atrial flutter, congenital heart disease, valvular heart disease, other cardiac arrhythmia, other cardiac disease.
LVH, left ventricular hypertrophy.
to be associated with increased risk of sudden death.1 3 15 
Consequently, some patients with these ECG abnormal-
ities may carry a high risk of OHCA, but the detection 
value is blurred by other low-risk patients having these 
ECG criteria without cardiac disease.
A recent study by Waks et al suggested that patients 
with a 10-year risk of sudden cardiac death between 1% 
and 5% should be considered at intermediate risk while 
patients with a 10-year risk >5% should be considered at 
high risk.29 In our study, 60-year and 70-year-old men with 
known cardiac disease and LBBB, ST-depression or NSIB 
had the highest risk of OHCA (10-year risk >5%). In 
addition, the risk of OHCA for 70-year-old men without 
known cardiac disease exceeded 5% when LBBB or NSIB 
was present in the ECG. Furthermore, 50-year-old men 
without known cardiac disease had an intermediate risk 
above 2% when one of the three ECG abnormalities was 
present in the ECG.
It has been reported that 40%–60% of all sudden 
cardiac deaths occur as the first manifestation of previ-
ously undetected heart disease.2 3 This was also the case in 
our study. This seriously challenges the option of taking 
preventive steps for reducing the occurrence of OHCA 
and sudden cardiac death. Screening for sudden cardiac 
death in general communities is not recommended in 
previous reports.3 11 Meanwhile, a recent study has shown 
that ECG abnormalities in asymptomatic middle-aged 
people predict fatal cardiac events.30 New risk models 
for predicting sudden cardiac death using advanced 
ECG parameters have been suggested, but clinical imple-
mentation has remained scarce.29 This could be due to 
the difficulty of implementation and interpretation of 
advanced ECG parameter in the primary care setting. This 
poses a problem for detecting patients at risk of sudden 
cardiac death, but without identified cardiac disease as 
such patients are rarely seen in secondary care settings. 
Even with no screening in the primary care setting, many 
patients have routine ECG examinations and knowledge 
about risk of sudden cardiac death when ECG abnormal-
ities are encountered is essential for optimal handling of 
these patients. This is illustrated by the fact that 14% of 
the patients suffering from OHCA without known cardiac 
disease at the time of the OHCA had high-risk ECG abnor-
malities at baseline. For patients presenting with serious 
ECG abnormalities in a primary care setting, consistent 
with cardiac disease, preventive measures such as referral 
to a secondary care evaluation should be considered.
limitations
A major limitation of our study is the observational 
design. As such, our results should be interpreted only 
as associative and not causal relations to OHCA. In addi-
tion, the design precludes assurance that unmeasured 
potential confounders could have been present and 
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Figure 2 Multivariable Cox regression model showing the 
association between different ECG abnormalities and out-
of-hospital cardiac arrest. Legend: The figure shows the 
results from the multivariable Cox regression model (AF, 
ST-depression, Q-wave, atrial flutter, Cornell hypertrophy, 
Sokolow-Lyon hypertrophy, ST-elevation, LBBB, RBBB and 
NSIB), adjusted for age and sex. An interaction was identified 
between AF and ST-depression (p<0.01 for interaction). AF, 
atrial fibrillation; LBBB, left bundle branch block; RBBB, right 
bundle branch block.
biassed the results. Our study population is not neces-
sarily generalisable to the general population. Our study 
population consisted of patients getting an ECG exami-
nation in a centralised primary care setting facility. The 
lack of generalisability is reflected in the higher incidence 
of OHCA, cardiovascular disease and all-cause mortality 
compared with the general population.12 13 31 However, 
this is not only a limitation as normal healthy people do 
not routinely undergo ECG recording and thus our study 
population is more likely to be representative of a real-life 
situation. Patients suffering from OHCA only included 
patients where a resuscitative attempt was performed 
excluding patients with late signs of death. Consequently, 
our incidence and risk estimations of OHCA are likely 
underestimations. Another major limitation of our study 
is that patient symptoms and the reasons why the ECG 
was requisitioned are unknown.
COnClusIOns
This study shows that several common ECG findings in a 
primary care setting are associated with OHCA, especially 
LBBB, ST-depression without concomitant atrial fibrilla-
tion and NSIB. Furthermore, 14% of patients without 
known heart disease had these ECG abnormalities prior 
to the OHCA event.
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